Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone Adjunct to Ranibizumab in AMD
NCT00511706Phase 2Completed
- Sponsor
- Allergan
- Start
- Nov 2007
- Primary completion
- Mar 2009
- Modality
- Orthosteric Ligands
- Countries
- 9
01
Overview
A Phase 2 trial of dexamethasone in choroidal neovascularization (CNV), age-related macular degeneration (AMD), sponsored by Allergan. Started Nov 2007; status: completed.
02
Drugs
dexamethasone
03
Conditions
choroidal neovascularization (CNV)age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT00511706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00511706.